1-[(5S,8S,11R,21R)-5,8-bis(4-aminobutyl)-11-(cyclohexylmethyl)-4,7,10,13,17,20-hexaoxo-1-oxa-3,6,9,12,16,19-hexazacyclotricos-21-yl]guanidine trifluoroacetate

ID: ALA5172706

Chembl Id: CHEMBL5172706

PubChem CID: 168271181

Max Phase: Preclinical

Molecular Formula: C34H60F3N11O9

Molecular Weight: 709.89

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)N[C@@H]1CCOCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2CCCCC2)NC(=O)CCNC(=O)CNC1=O.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C32H59N11O7.C2HF3O2/c33-14-6-4-10-22-29(47)39-20-50-17-13-24(43-32(35)36)28(46)38-19-27(45)37-16-12-26(44)40-25(18-21-8-2-1-3-9-21)31(49)42-23(30(48)41-22)11-5-7-15-34;3-2(4,5)1(6)7/h21-25H,1-20,33-34H2,(H,37,45)(H,38,46)(H,39,47)(H,40,44)(H,41,48)(H,42,49)(H4,35,36,43);(H,6,7)/t22-,23-,24+,25+;/m0./s1

Standard InChI Key:  GAMPLFDDPCNJMI-UDRIRSMNSA-N

Associated Targets(non-human)

F2 Thrombin (1630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypsin (394 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 709.89Molecular Weight (Monoisotopic): 709.4599AlogP: -2.36#Rotatable Bonds: 11
Polar Surface Area: 297.77Molecular Species: BASEHBA: 10HBD: 11
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.68CX Basic pKa: 11.05CX LogP: -4.15CX LogD: -11.22
Aromatic Rings: Heavy Atoms: 50QED Weighted: 0.06Np Likeness Score: 0.62

References

1. Huber S, Braun NJ, Schmacke LC, Quek JP, Murra R, Bender D, Hildt E, Luo D, Heine A, Steinmetzer T..  (2022)  Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors.,  65  (9.0): [PMID:35475620] [10.1021/acs.jmedchem.1c01860]

Source